Category: Blood Cancer

Leading UK private insurer first to reimburse MMprofiler for insured patients

Everything Genetic is pleased to announce that it has partnered with a leading UK private health insurance company to design an access strategy for patients with multiple myeloma (blood cancer) to get reimbursement for a novel molecular diagnostic test. Patients that are eligible in the United Kingdom are the first to have reimbursed access to… Read more »